Insider Selling: Pacira BioSciences, Inc. (NASDAQ:PCRX) Director Sells $24,974.40 in Stock
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) Director Paul J. Hastings sold 880 shares of the stock in a transaction that occurred on Thursday, June 13th. The shares were sold at an average price of $28.38, for a total transaction of $24,974.40. Following the completion of the transaction, the director now directly owns 12,724 […]
More Stories
Sprott Junior Copper Miners ETF (NASDAQ:COPJ) Short Interest Update
Sprott Junior Copper Miners ETF (NASDAQ:COPJ – Get Free Report) saw a significant growth in short interest during the month...
‘Complete Obliteration’: DeSantis Says Hurricane Helene Damage Worse Than Idalia
By T. J. Muscaro TAMPA—Florida’s Gov. Ron DeSantis said Hurricane Helene’s “monumental storm surge” caused far greater damage than last...
US and Iraq Announce Changes to Military Footprint After Years-Long Joint Fight Against ISIS
By Chase Smith In a joint statement released on Sept. 27, the United States and Iraq announced plans for a...
Nestlé S.A. (OTCMKTS:NSRGY) Short Interest Up 152.5% in September
Nestlé S.A. (OTCMKTS:NSRGY – Get Free Report) saw a significant growth in short interest in September. As of September 15th,...
Short Interest in BlackRock Capital Allocation Term Trust (NYSE:BCAT) Expands By 100.6%
BlackRock Capital Allocation Term Trust (NYSE:BCAT – Get Free Report) was the recipient of a large growth in short interest...
Cenovus Energy Inc. (NYSE:CVE) Sees Significant Growth in Short Interest
Cenovus Energy Inc. (NYSE:CVE – Get Free Report) (TSE:CVE) was the target of a significant increase in short interest in...